MDGL Stock Price
Madrigal Pharmaceuticals, Inc.
$460.01
+$7.89(+1.75%)
40
Overall
40
Value
36
Tech
44
Quality
Market Cap
$10.45B
Volume
326.94K
52W Range
$393.61 - $615.00
Target Price
$675.50
MDGL stock price is $460.01 (+1.75% on the day), giving Madrigal Pharmaceuticals, Inc. a market cap of $10.45B. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
MDGL Stock Overview
- Price
- $460.01
- Previous close
- $452.12
- Open
- $455.52
- Market cap
- $10.45B
- P/E ratio
- -36.2
- 52-week range
- $393.61 - $615.00
- 1-year price target
- $675.50
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- NGS
- MarketXLS Rank
- 40
About Madrigal Pharmaceuticals, Inc.
Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. The company offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company is headquartered in West Conshohocken, Pennsylvania.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MDGL | $460.01 | +1.7% | 326.94K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Madrigal Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW